[Infusion therapy in cardio-pulmonary insufficiency (author's transl)].
The pathogenesis of cardiopulmonary insufficiency in intensive-care patients is reviewed, with special reference to the development of interstitial pulmonary oedema. Measures designed to control the condition and compensate for the increased post-operative and post-traumatic calorie and aminoacid requirements are: 1. restricted fluid intake; 2. digitalization and administration of diuretics; 3. administration of highly concentrated human albumin. Potential pulmonary reactions to, and possible beneficial effects of, parenteral fat administration are discussed.
D000804:Angiotensin II / Q000378:metabolism; D001798:Blood Proteins; D002302:Cardiac Output; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D007362:Intensive Care Units; D008465:Mechanoreceptors; D010288:Parenteral Nutrition; D012083:Renin / Q000378:metabolism; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000628:therapy; D013898:Thoracic Injuries / Q000628:therapy; D014883:Water-Electrolyte Imbalance / Q000628:therapy
D001798:Blood Proteins; D000804:Angiotensin II; D012083:Renin
Infusionstherapie bei kardiopulmonaler Insuffizienz.